ABC 10-K Annual Report Sept. 30, 2023 | Alphaminr
AMERISOURCEBERGEN CORP
ALPHAMINR

ABC 10-K Fiscal year ended Sept. 30, 2023

Balance Sheet
Cash Flow
Income Statement
Debt
AMERISOURCEBERGEN CORP
10-Ks and 10-Qs
10-Q
 		Quarter ended March 31, 2024
10-Q
 		Quarter ended Dec. 31, 2023
10-K
 		Fiscal year ended Sept. 30, 2023
10-Q
 		Quarter ended June 30, 2023
10-Q
 		Quarter ended March 31, 2023
10-Q
 		Quarter ended Dec. 31, 2022
10-K
 		Fiscal year ended Sept. 30, 2022
10-Q
 		Quarter ended June 30, 2022
10-Q
 		Quarter ended March 31, 2022
10-Q
 		Quarter ended Dec. 31, 2021
10-K
 		Fiscal year ended Sept. 30, 2021
10-Q
 		Quarter ended June 30, 2021
10-Q
 		Quarter ended March 31, 2021
10-Q
 		Quarter ended Dec. 31, 2020
10-K
 		Fiscal year ended Sept. 30, 2020
10-Q
 		Quarter ended June 30, 2020
10-Q
 		Quarter ended March 31, 2020
10-Q
 		Quarter ended Dec. 31, 2019
10-K
 		Fiscal year ended Sept. 30, 2019
10-Q
 		Quarter ended June 30, 2019
10-Q
 		Quarter ended March 31, 2019
10-Q
 		Quarter ended Dec. 31, 2018
10-K
 		Fiscal year ended Sept. 30, 2018
10-Q
 		Quarter ended June 30, 2018
10-Q
 		Quarter ended March 31, 2018
10-Q
 		Quarter ended Dec. 31, 2017
10-K
 		Fiscal year ended Sept. 30, 2017
10-Q
 		Quarter ended June 30, 2017
10-Q
 		Quarter ended March 31, 2017
10-Q
 		Quarter ended Dec. 31, 2016
10-K
 		Fiscal year ended Sept. 30, 2016
10-Q
 		Quarter ended June 30, 2016
10-Q
 		Quarter ended March 31, 2016
10-Q
 		Quarter ended Dec. 31, 2015
10-K
 		Fiscal year ended Sept. 30, 2015
10-Q
 		Quarter ended June 30, 2015
10-Q
 		Quarter ended March 31, 2015
10-Q
 		Quarter ended Dec. 31, 2014
10-K
 		Fiscal year ended Sept. 30, 2014
10-Q
 		Quarter ended June 30, 2014
10-Q
 		Quarter ended March 31, 2014
10-Q
 		Quarter ended Dec. 31, 2013
10-K
 		Fiscal year ended Sept. 30, 2013
10-Q
 		Quarter ended June 30, 2013
10-Q
 		Quarter ended March 31, 2013
10-Q
 		Quarter ended Dec. 31, 2012
10-K
 		Fiscal year ended Sept. 30, 2012
10-Q
 		Quarter ended June 30, 2012
10-Q
 		Quarter ended March 31, 2012
10-Q
 		Quarter ended Dec. 31, 2011
10-K
 		Fiscal year ended Sept. 30, 2011
10-Q
 		Quarter ended June 30, 2011
10-Q
 		Quarter ended March 31, 2011
10-Q
 		Quarter ended Dec. 31, 2010
10-K
 		Fiscal year ended Sept. 30, 2010
10-Q
 		Quarter ended June 30, 2010
10-Q
 		Quarter ended March 31, 2010
10-Q
 		Quarter ended Dec. 31, 2009
PROXIES
DEF 14A
 		Filed on Jan. 29, 2024
DEF 14A
 		Filed on Jan. 27, 2023
DEF 14A
 		Filed on Jan. 27, 2022
DEF 14A
 		Filed on Jan. 28, 2021
DEF 14A
 		Filed on Jan. 24, 2020
DEF 14A
 		Filed on Jan. 18, 2019
DEF 14A
 		Filed on Jan. 19, 2018
DEF 14A
 		Filed on Jan. 20, 2017
DEF 14A
 		Filed on Jan. 22, 2016
DEF 14A
 		Filed on Jan. 23, 2015
DEF 14A
 		Filed on Jan. 24, 2014
DEF 14A
 		Filed on Jan. 18, 2013
DEF 14A
 		Filed on Jan. 20, 2012
DEF 14A
 		Filed on Jan. 14, 2011
DEF 14A
 		Filed on Jan. 22, 2010
TABLE OF CONTENTS
Part IItem 1. BusinessItem 1A. Risk FactorsItem 1B. Unresolved Staff CommentsItem 2. PropertiesItem 3. Legal ProceedingsItem 4. Mine Safety DisclosuresPart IIItem 5. Market For Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases Of Equity SecuritiesItem 6. [reserved]Item 7. Management's Discussion and Analysis Of Financial Condition and Results Of OperationsPart By Recent Initiatives Undertaken To Improve Operating Efficiency Across Many Of Our Businesses and Administrative FunctionsItem 7A. Quantitative and Qualitative Disclosures About Market RiskItem 8. Financial Statements and Supplementary DataNote 1. Summary Of Significant Accounting PoliciesNote 2. Acquisitions and Equity Method InvestmentNote 3. Variable Interest EntityNote 4. Income TaxesNote 5. Goodwill and Other Intangible AssetsNote 6. DebtNote 7. Stockholders' Equity and Weighted Average Common Shares OutstandingNote 8. Related Party TransactionsNote 9. Retirement and Other Benefit PlansNote 10. Share-based CompensationNote 11. LeasesNote 12. Restructuring and Other ExpensesNote 13. Legal Matters and ContingenciesNote 14. Litigation SettlementsNote 15. Business Segment InformationNote 16. Fair Value Of Financial InstrumentsNote 17. Subsequent EventItem 9. Changes in and Disagreements with Accountants on Accounting and Financial DisclosureItem 9A. Controls and ProceduresItem 9B. Other InformationItem 9C. Disclosure Regarding Foreign Jurisdictions That Prevent InspectionsPart IIIItem 10. Directors, Executive Officers and Corporate GovernanceItem 11. Executive CompensationItem 12. Security Ownership Of Certain Beneficial Owners and Management and Related Stockholder MattersItem 13. Certain Relationships and Related Transactions, and Director IndependenceItem 14. Principal Accountant Fees and ServicesPart IVItem 15. Exhibits and Financial Statement SchedulesItem 16. Form 10-k Summary

Exhibits

2.1 Share Purchase Agreement, by and between Walgreens Boots Alliance, Inc. and AmerisourceBergen Corporation, dated as of January 6, 2021 (incorporated by reference to Exhibit 2.1 to the Registrant's Current Report on Form 8-K filed on January 8, 2021). 3.1 Amended and Restated Certificate of Incorporation of the Registrant, dated as of August 30, 2023 (incorporated by reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K filed on August 30, 2023). 3.2 Amended and Restated Bylaws of the Registrant, dated as of August 30, 2023 (incorporated by reference to Exhibit 3.2 to the Registrant's Current Report on Form 8-K filed on August 30, 2023). 4.1 Indenture, dated as of November19, 2009, between the Registrant and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit4.1 to the Registrant's Current Report on Form8-K filed on November23, 2009). 4.2 Fourth Supplemental Indenture, dated as of May22, 2014, between the Registrant and U.S. Bank National Association, as trustee, related to Registrant's 3.400% Senior Notes due 2024 (incorporated by reference to Exhibit4.2 to the Registrant's Current Report on Form8-K filed on May22, 2014). 4.3 Form of 3.400% Senior Notes due 2024 (incorporated by reference to ExhibitA to Fourth Supplemental Indenture, dated as of May22, 2014, between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 3.400% Senior Notes due 2024, which is filed as Exhibit4.2 to the Registrant's Current Report on Form8-K filed on May22, 2014). 4.4 Fifth Supplemental Indenture, dated as of February20, 2015, between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 3.250% Senior Notes due 2025 (incorporated by reference to Exhibit4.1 to the Registrant's Current Report on Form8-K filed on February20, 2015). 4.5 Form of 3.250% Senior Notes due 2025 (incorporated by reference to ExhibitA to Fifth Supplemental Indenture, dated as of February20, 2015 between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 3.250% Senior Notes due 2025, which is filed as Exhibit4.1 to the Registrant's Current Report on Form8-K filed on February20, 2015). 4.6 Sixth Supplemental Indenture, dated as of February20, 2015, between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 4.250% Senior Notes due 2045 (incorporated by reference to Exhibit4.2 to the Registrant's Current Report on Form8-K filed on February20, 2015). 4.7 Form of 4.250% Senior Notes due 2045 (incorporated by reference to ExhibitA to Sixth Supplemental Indenture, dated as of February20, 2015 between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 4.250% Senior Notes due 2045, which is filed as Exhibit4.2 to the Registrant's Current Report on Form8-K filed on February20, 2015). 4.8 Seventh Supplemental Indenture, dated as of December 4, 2017, between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 3.450% Senior Notes due 2027 (incorporated by reference to Exhibit4.1 to the Registrant's Current Report on Form8-K filed on December 5, 2017). 4.9 Form of 3.450% Senior Notes due 2027 (incorporated by reference to ExhibitA to Seventh Supplemental Indenture, dated as of December 4, 2017 between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 3.450% Senior Notes due 2027, which is filed as Exhibit4.1 to the Registrant's Current Report on Form8-K filed on December 5, 2017). 4.10 Eighth Supplemental Indenture, dated as of December 4, 2017, between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 4.300% Senior Notes due 2047 (incorporated by reference to Exhibit4.2 to the Registrant's Current Report on Form8-K filed on December 5, 2017). 4.11 Form of 4.300% Senior Notes due 2047 (incorporated by reference to ExhibitA to Eighth Supplemental Indenture, dated as of December 4, 2017 between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 4.300% Senior Notes due 2047, which is filed as Exhibit4.2 to the Registrant's Current Report on Form8-K filed on December 5, 2017). 4.12 Ninth Supplemental Indenture, dated as of May 19, 2020, between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 2.800% Senior Notes due 2030 (incorporated by reference to Exhibit4.1 to the Registrant's Current Report on Form8-K filed on May 19, 2020). 4.13 Form of 2.800% Senior Notes due 2030 (incorporated by reference to ExhibitA to Ninth Supplemental Indenture, dated as of May 19, 2020 between the Registrant and U.S. Bank National Association, as trustee, related to the Registrant's 2.800% Senior Notes due 2030, which is filed as Exhibit4.1 to the Registrant's Current Report on Form8-K filed on May 19, 2020). 4.14 Eleventh Supplemental Indenture, dated March 30, 2021, by and between AmerisourceBergen Corporation and U.S. Bank National Association (including Form of 2.700% Senior Note due 2031) (incorporated by reference to Exhibit 4.2 to the Registrant's Current Report on Form 8-K filed on April 1, 2021). 4.15 Form of 2.700% Senior Note due 2031 (incorporated by reference to Exhibit A to Eleventh Supplemental Indenture, dated March 30, 2021, by and between AmerisourceBergen Corporation and U.S. Bank National Association, as trustee, related to the Registrant's 2.700% Senior Notes Due 2031, which is filed as Exhibit 4.2 to the Registrant's Current Report on Form 8-K filed on April 1, 2021). 4.16 Description of the Registrant's Securities. 10.1 Framework Agreement, dated as of March18, 2013, by and among the Registrant, WalgreenCo. and Alliance BootsGmbH (incorporated by reference to Exhibit10.1 to the Registrant's Current Report on Form8-K filed on March20, 2013). 10.2 Amended and Restated AmerisourceBergen Shareholders Agreement, dated as of June 1, 2021, between AmerisourceBergen Corporation and Walgreens Boots Alliance, Inc. (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on June 2, 2021). 10.3 Amendment No. 1 to the Amended and Restated Shareholders Agreement, dated as of August 2, 2022, by and between AmerisourceBergen Corporation and Walgreens Boots Alliance, Inc. (incorporated by reference to Exhibit 10.2 to the Registrant's Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2022). 10.4 AmerisourceBergen Corporation 2001 Deferred Compensation Plan, as amended and restated as of November24, 2008 (incorporated by reference to Exhibit10.19 to the Registrant's Annual Report on Form10-K for the fiscal year ended September30, 2008). 10.5 AmerisourceBergen Corporation Equity Incentive Plan, as amended and restated as of January 1, 2011(incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on February 25, 2013). 10.6 Form of Nonqualified Stock Option Award Agreement to Employee under the AmerisourceBergen Corporation Equity Incentive Plan (incorporated by reference to Exhibit 10.10 to the Registrant's Annual Report on Form 10-K for the fiscal year ended September 30, 2013). 10.7 AmerisourceBergen Corporation Amended and Restated Employee Stock Purchase Plan, as amended and restated on March 2, 2018 (incorporated by reference to Exhibit10.1 to the Registrant's Quarterly Report on Form10-Q for the fiscal quarter ended March 31, 2018). 10.8 AmerisourceBergen Corporation Benefit Restoration Plan, as amended and restated as of December1, 2013 (incorporated by reference to Exhibit10.1 to the Registrant's Current Report on Form8-K filed on December5, 2013). 10.9 AmerisourceBergen Corporation Omnibus Incentive Plan (incorporated by reference to Exhibit10.1 to the Registrant's Current Report on Form8-K filed on March10, 2014). 10.10 AmerisourceBergen Corporation 2022 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on April 1, 2022). 10.11 Form of Restricted Stock Unit Agreement to Non-Employee Director under the AmerisourceBergen Corporation Omnibus Incentive Plan (incorporated by reference to Exhibit10.3 to the Registrant's Current Report on form8-K filed on March10, 2014). 10.12 Form of 2014 Nonqualified Stock Option Award Agreement to Employee under the AmerisourceBergen Corporation Omnibus Incentive Plan (incorporated by reference to Exhibit 10.4 to the Registrant's Current Report on Form 8-K filed on March 10, 2014). 10.13 Form of 2019 Nonqualified Stock Option Award Agreement to Employee under the AmerisourceBergen Corporation Omnibus Incentive Plan (incorporated by reference to Exhibit10.7 to the Registrant's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2018). 10.14 Form of 2019 Restricted Stock Unit Agreement to Employee under the AmerisourceBergen Corporation Omnibus Incentive Plan (incorporated by reference to Exhibit10.8 to the Registrant's Quarterly Report on Form10-Q for the fiscal quarter ended December 31, 2018). 10.15 Form of 2019 Performance Share Award Agreement to Employee under the AmerisourceBergen Corporation Omnibus Incentive Plan (incorporated by reference to Exhibit10.9 to the Registrant's Quarterly Report on Form10-Q for the fiscal quarter ended December 31, 2018). 10.16 Form of 2020 Restricted Stock Unit Agreement to Employee under the AmerisourceBergen Corporation Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Registrants Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2020). 10.17 Form of 2021 Performance Share Award Agreement to Employee under the AmerisourceBergen Corporation Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Registrant's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2021). 10.18 Form of Restricted Stock Unit Award Agreement to Non-Employee Director under the AmerisourceBergen Corporation 2022 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Registrant's Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2022). 10.19 AmerisourceBergen Corporation Financial Recoupment Policy (incorporated by reference to Exhibit 10.10 to the Registrants Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2018). 10.20 Form of Restricted Stock Unit Award Agreement to Employee under the AmerisourceBergen Corporation 2022 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.23 to the Registrant's Annual Report on Form 10-K for the fiscal year ended September 30, 2022). 10.21 Form of Performance Share Award Unit Award Agreement to Employee under the AmerisourceBergen Corporation 2022 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.24 to the Registrant's Annual Report on Form 10-K for the fiscal year ended September 30, 2022). 10.22 Amended and Restated Employment Agreement, dated as of January 11, 2019, between the Company and Steven H. Collis (incorporated by reference to Exhibit 10.1 to the Registrants Current Report on Form 8-K filed on January 11, 2019). 10.23 Form of Employment Agreement applicable to executive officers (incorporated by reference to Exhibit 10.3 to the Registrants Current Report on Form 8-K filed on January 11, 2019). 10.24 Amended and Restated Receivables Sale Agreement, dated as of October 16, 2020, among AmeriSource Receivables Financial Corporation, as buyer, and AmerisourceBergen Drug Corporation and ASD Specialty Healthcare, LLC, as originators (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on October 19, 2020). 10.25 Amended and Restated Receivables Purchase Agreement, dated as of April29, 2010, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the various purchaser groups party thereto, and Bank of America, National Association, as administrator (incorporated by reference to Exhibit99.1 to the Registrant's Current Report on Form8-K filed on May5, 2010). 10.26 First Amendment to Amended and Restated Receivables Purchase Agreement, dated as of April28, 2011, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the purchaser agents and purchasers party thereto, and Bank of America, National Association, as administrator (incorporated by reference to Exhibit10.1 to the Registrant's Current Report on Form8-K filed on May4, 2011). 10.27 Second Amendment to Amended and Restated Receivables Purchase Agreement, dated as of October28, 2011, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, servicer, the purchaser agents and purchasers party thereto, and Bank of America, National Association, as administrator (incorporated by reference to Exhibit10.3 to the Registrant's Current Report on Form8-K filed on October28, 2011). 10.28 Third Amendment to Amended and Restated Receivables Purchase Agreement, dated as of November16, 2012, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the purchaser agents and purchasers party thereto, and Bank of America, National Association, as administrator (incorporated by reference to Exhibit10.1 to the Registrant's Current Report on Form8-K filed on November21, 2012). 10.29 Fourth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of January16, 2013, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the purchaser agents and purchasers party thereto, and the Bank of Tokyo-Mitsubishi UFJ,Ltd., New York Branch, as administrator (incorporated by reference to Exhibit10.1 to the Registrant's Current Report on form8-K filed on January17, 2013). 10.30 Fifth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of June28, 2013, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the purchaser agents and purchasers party thereto, and the Bank of Tokyo-Mitsubishi UFJ,Ltd., New York Branch, as administrator (incorporated by reference to Exhibit10.1 to the Registrant's Current Report on Form8-K filed on July3, 2013). 10.31 Sixth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of October7, 2013, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the purchaser agents and purchasers party thereto, Market Street FundingLLC, as assignor, PNC Bank, National Association, as assignee, and the Bank of Tokyo-Mitsubishi UFJ,LTD., New York Branch, as administrator (incorporated by reference to Exhibit10.1 to the Registrant's Current Report on Form8-K filed on October10, 2013). 10.32 Seventh Amendment to Amended and Restated Receivables Purchase Agreement, dated as of July17, 2014, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the purchaser agents and purchasers party thereto and the Bank of Tokyo-Mitsubishi UFJ,Ltd., New York Branch, as Administrator (incorporated by reference to Exhibit10.1 to the Registrant's Current Report on Form8-K filed on July22, 2014). 10.33 Eighth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of December5, 2014, by and among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the purchaser agents and purchasers party thereto, and The Bank of Tokyo-Mitsubishi UFJ,Ltd., New York Branch, as administrator (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form8-K filed on December8, 2014). 10.34 Omnibus Amendment, dated November 4, 2015 to the Amended and Restated Receivables Purchase Agreement, dated as of April 29, 2010, as amended, among AmeriSource Receivables Financial Corporation, as Seller, AmerisourceBergen Drug Corporation, as Servicer, the Purchaser Agents and Purchasers party thereto and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as Administrator (incorporated by reference to Exhibit 10.1 to the Registrants Current Report on Form 8-K filed on November 4, 2015). 10.35 Tenth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of June 21, 2016, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, Working Capital Management Co., LP, as assignor, Advantage Asset Securitization Corp., Mizuho Bank, Ltd., as assignee, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as administrator (incorporated by reference to Exhibit 10.1 to the Registrants Current Report on Form 8-K filed on June 23, 2016). 10.36 Eleventh Amendment to Amended and Restated Receivables Purchase Agreement, dated as of November 18, 2016, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as administrator (incorporated by reference to Exhibit 10.4 to the Registrants Current Report on Form 8-K filed on November 22, 2016). 10.37 Twelfth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of December 18, 2017, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as administrator (incorporated by reference to Exhibit 10.2 to the Registrants Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2017). 10.38 Thirteenth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of October 31, 2018, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, and MUFG Bank, Ltd. (f/k/a The Bank of Tokyo-Mitsubishi UFJ, Ltd.), as administrator (incorporated by reference to Exhibit 10.3 to the Registrant's Current Report on Form 8-K filed on November 6, 2018). 10.39 Fourteenth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of September 18, 2019, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, and MUFG Bank, Ltd., as administrator (incorporated by reference to Exhibit 10.3 to the Registrants Current Report on Form 8-K filed on September 23, 2019). 10.40 Fifteenth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of October 16, 2020, among AmeriSource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, and MUFG Bank, Ltd., as administrator (incorporated by reference to Exhibit 10.2 to the Registrant's Current Report on Form 8-K filed on October 19, 2020). 10.41 Omnibus Amendment, dated as of May 13, 2021, constituting (i) the First Amendment to Amended and Restated Receivables Sale Agreement, among AmerisourceBergen Drug Corporation and ASD Specialty Healthcare, LLC, as originators, and Amerisource Receivables Financial Corporation, as buyer and (ii) the Sixteenth Amendment to Amended and Restated Receivables Purchase Agreement, among Amerisource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, and MUFG Bank, Ltd., as administrator (incorporated by reference to Exhibit 10.4 to the Registrant's Current Report on Form 8-K filed on May 14, 2021). 10.42 Seventeenth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of November 4, 2021, among Amerisource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, and MUFG Bank, Ltd., as administrator (incorporated by reference to Exhibit 10.3 to the Registrant's Current Report on Form 8-K filed on November 8, 2021). 10.43 Eighteenth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of October 21, 2022, among Amerisource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, and MUFG Bank, Ltd., as administrator (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on October 24, 2022). 10.44 Nineteenth Amendment to Amended and Restated Receivables Purchase Agreement, dated as of May 3, 2023, among Amerisource Receivables Financial Corporation, as seller, AmerisourceBergen Drug Corporation, as servicer, the Purchaser Agents and Purchasers party thereto, and MUFG Bank, Ltd., as administrator (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on May 5, 2023). 10.45 Second Amended and Restated Performance Undertaking Agreement, dated as of October 16, 2020, executed by AmerisourceBergen Corporation, as performance guarantor (incorporated by reference to Exhibit 10.3 to the Registrant's Current Report on Form 8-K filed on October 19, 2020). 10.46 Amended and Restated Credit Agreement, dated as of October 27, 2022, among AmerisourceBergen Corporation, the borrowing subsidiaries party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on October 27, 2022). 10.47 Amended and Restated Credit Agreement, dated as of October6, 2023, among Cencora, Inc., the borrowing subsidiaries party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on October 10, 2023). 10.48 Distributor Settlement Agreement, dated as of March 25, 2022, between and among the Settling States, the Settling Distributors, and the Participating Subdivisions (as defined therein) (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K/A filed on May 3, 2022). 10.49 Share Repurchase Agreement, dated as of November 6, 2022, by and between AmerisourceBergen Corporation and Walgreens Boots Alliance Holdings LLC (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on November 10, 2022). 10.50 Share Repurchase Agreement, dated as of December 8, 2022, by and between AmerisourceBergen Corporation and Walgreens Boots Alliance Holdings LLC (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form8-K filed on December 12, 2022). 10.51 Share Repurchase Agreement, dated as of May 11, 2023, by and between AmerisourceBergen Corporation and Walgreens Boots Alliance Holdings LLC (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on May 15, 2023). 10.52 Share Repurchase Agreement, dated as of June 15, 2023, by and between AmerisourceBergen Corporation and Walgreens Boots Alliance Holdings LLC (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on June 20, 2023). 10.53 Share Repurchase Agreement, dated as of August 2, 2023, by and between AmerisourceBergen Corporation and Walgreens Boots Alliance Holdings LLC(incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on August 8, 2023). 10.54 Share Repurchase Agreement, dated as of November 9, 2023, by and between Cencora, Inc. and Walgreens Boots Alliance Holdings LLC(incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on November14, 2023). 21 Subsidiaries of the Registrant. 23 Consent of Ernst& YoungLLP, Independent Registered Public Accounting Firm. 31.1 Rule13a-14(a)/15d-14(a) Certification of Chief Executive Officer. 31.2 Rule13a-14(a)/15d-14(a) Certification of Chief Financial Officer. 32 Section1350 Certifications of the Chief Executive Officer and Chief Financial Officer. 97 Dodd-Frank Compensation Recoupment Policy.